1.A Change in Anterior Chamber Depth Between with Accommodation and Without Accommodation in Pseudophakic Eyes.
Hyeong Seog SHIM ; Ji Myeong YOO ; Jong Moon PARK
Journal of the Korean Ophthalmological Society 1992;33(5):490-494
A group of pseudophakic patients (21eyes) without complications, such as zonular dam age, posterior synechia and posterior capsular tear, was investigated to determine whether their implants (pharmacia, cilco, AMO) shift under the ciliary muscle stimulation. A change in anterior chamber depth between with accommodation and without accommodation was found. By presenting as accommodation stimulus to the normal fellow eye, the intraocular lens in the pseudophakic eye moved slightly in a forward direction. But, it is not enough to explain apparent accommodation in pseudophakic eyes.
Anterior Chamber*
;
Humans
;
Lenses, Intraocular
2.A Clinical Study on Rhegmatogenous Retinal Detachment.
Jong Moon PARK ; Hyeong Seog SHIM ; Ji Hong BAE
Journal of the Korean Ophthalmological Society 1993;34(11):1154-1161
Authors analysed the clinical characteristics and the surgical results of rhegmatogenous retinal detachment in 70 patients(71 eyes) who were operated GNUH from Feb. 1990 to Feb. 1992. The clinical characteristics of rhegmatogenous retinal detachment were as follows. The result was myopia(39.4%) as the most common associated ocular finding, one break(57.7%) as the number of break, two quadrants(33.8%) as the extent of retinal detachmenthole(53.5%) as the type of break and superior temporal portion(56.3%) and anterior portion including equator(83.1%) as the location of break. The success rate of first operation was 87.3% and the overall success rate of rhegmatogenous retinal detachment maintained anatomical attachment above 6 months and exeluded 3 cases of refused reoperation was 92.3%. The type of break extent of detachment and duration of detachment were not influenced to surgical success rate statistically(P>0.05). The most common cause of first operative failure was proliferative vitreoretinopathy(57%).
Reoperation
;
Retinal Detachment*
;
Retinaldehyde*
3.A case of pulmonary veno-occlusive disease in primary pulmonary hypertension.
Hong Seog SEO ; Kyeong Ho KANG ; Hye Hyeong KIM ; Do Sun LIM ; Chang Kyu PARK ; Young Hoon KIM ; Wan Joo SHIM ; Dong Joo OH ; Jeong Euy PARK ; Young Moo RO ; Dong Kyu JIN
Korean Journal of Medicine 1993;45(3):400-406
No abstract available.
Hypertension, Pulmonary*
;
Pulmonary Veno-Occlusive Disease*
4.A prospective randomized study of cisplatin versus PEV(cisplatin, etoposide, vinblastine) chemotherapy in advanced non-small cell lung cancer.
Ki Hyeong LEE ; Won Ki KANG ; Joung Soon JUNG ; Sung Soo YOON ; Young Hyuk IM ; Jae Yong LEE ; Young Suk PARK ; Chang In SUH ; Dae Seog HEO ; Yung Jue BANG ; Young Soo SHIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(2):256-267
No abstract available.
Carcinoma, Non-Small-Cell Lung*
;
Cisplatin*
;
Drug Therapy*
;
Etoposide*
;
Prospective Studies*
5.Impact of Cigarette Smoking: a 3-Year Clinical Outcome of Vasospastic Angina Patients.
Byoung Geol CHOI ; Seung Woon RHA ; Taeshik PARK ; Se Yeon CHOI ; Jae Kyeong BYUN ; Min Suk SHIM ; Shaopeng XU ; Hu LI ; Sang Ho PARK ; Ji Young PARK ; Woong Gil CHOI ; Yun Hyeong CHO ; Sunki LEE ; Jin Oh NA ; Cheol Ung CHOI ; Hong Euy LIM ; Jin Won KIM ; Eung Ju KIM ; Chang Gyu PARK ; Hong Seog SEO ; Dong Joo OH
Korean Circulation Journal 2016;46(5):632-638
BACKGROUND AND OBJECTIVES: Cigarette smoking is a risk significant factor in coronary artery disease (CAD) and vasospastic angina (VSA). However, it is largely unknown whether smoking adds to any long-term clinical risk in VSA patients. SUBJECTS AND METHODS: A total of 2797 patients without significant CAD underwent acetylcholine (Ach) provocation test between November 2004 and October 2010. Patients were divided into three groups, based on the presence of coronary artery spasm (CAS) and smoking habits (non-CAS group: n=1188, non-smoking CAS group: n=1214, smoking CAS group: n=395). All CAS patients were prescribed with anti-anginal medications for at least 6 months. The incidence of major clinical outcomes and recurrent angina of these groups were compared up to 3 years. RESULTS: There were considerable differences in the baseline clinical and angiographic characteristics among the three groups, but there was no difference in the endpoints among the three groups (including individual and composite hard endpoints) such as death, myocardial infarction, de novo percutaneous coronary intervention, cerebrovascular accident, and major adverse cardiac events. However, there was a higher incidence of recurrent angina in both the non-smoking CAS group and smoking CAS group, as compared to the non-CAS group. In multivariable adjusted Cox-proportional hazards regression analysis, smoking CAS group exhibited a higher incidence of recurrent angina compared with the non-CAS group (hazard ratio [HR]; 2.46, 95% confidence interval [CI]; 1.46-4.14, p=0.001) and non-smoking CAS group (HR; 1.76, 95% CI; 1.08-2.87, p=0.021). CONCLUSION: Cigarette smoking CAS group exhibited higher incidence of recurrent angina during the 3-year clinical follow-up compared with both the non-CAS group and non-smoking CAS group. Quitting of smoking, paired with intensive medical therapy and close clinical follow-up, can help to prevent recurrent angina.
Acetylcholine
;
Coronary Artery Disease
;
Coronary Vessels
;
Follow-Up Studies
;
Humans
;
Incidence
;
Myocardial Infarction
;
Percutaneous Coronary Intervention
;
Smoke
;
Smoking*
;
Spasm
;
Stroke
;
Tobacco Products*